ROCHE "SARS-coV-2 Rapid nasal antigen test"

Quality Standards: Complies with EN 455 and EN 374.

Complies with ASTM D6319 (USA Related Product)

 

Features: Rapid Chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in nasopharyngeal or combined nasopharyngeal/ oropharyngeal.

 

Quantity: 60,000,000 (Sixty Million) in 12 weeks

(5 million tests every week or 60 million in 1 month)

Tests: 50% boxes in 5 pcs and 50% in 25 pcs

 

Payment/warranty: Escrow/SBLC

T/T after SGS inspection (for the first 2 weeks in the airport and/or port from the third week of supply).

 

INCOTERMS SERVICE:

DDP EU (shipping to the US can also be quoted)

LOGO CE.jpg
FDA-Logo.jpg
ROCHE DIAGNOSTIC.jpg
ROCHE SARS-coV-2 Rapid nasal antigen test.png

INDICAID - COVID-19

Quality Standards: CE - FDA and EUA
(Emergency Use Authorization)

https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
 

Features: Rapid Chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in nasopharyngeal or combined nasopharyngeal/ oropharyngeal.

 

Quantity: 5,000,000 tests a month

 

Payment/warranty: SBLC and T/T after SGS inspection in US/EU

 

INCOTERMS SERVICE:

DDP US

LOGO CE.jpg
FDA-Logo.jpg
EUA.png
INDICAID.png
INDICAID.jpg